Indeed, human and murine hepatocellular carcinomas that show down-regulation of SIRT1 display significantly reduced expression of gluconeogenic enzymes and increased release of glucose into circulation, due to the activation of an IL-6-STAT3 signaling pathway leading to the up-regulation of miR-23a (48). The gene discussed is STAT3; the disease is hepatocellular carcinoma.